TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6128098

Group type: EXPERIMENTAL
Intervention: bamethan
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 30859478

Group type: EXPERIMENTAL
Intervention: Double entry
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: Solo read aloud
Number of subjects: 412

Group type: COMPARATOR
Intervention: Partner read aloud
Number of subjects: 412

Group type: COMPARATOR
Intervention: Visual checking
Number of subjects: 412
Study: 31190575

Group type: EXPERIMENTAL
Intervention: Quality of life measured using EQ‐5D‐5L questionnaires; mean utility was 0.88 per patient.
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Cost analysis using iMTA medical consumption questionnaire (iMCQ) and iMTA productivity costs questionnaire (iPCQ); three-month mean societal cost per patient amounted to €3,211.
Number of subjects: 178
Study: 29423865

Group type: EXPERIMENTAL
Intervention: High-volume corticosteroid injections (HCI) - 10 mL total volume of 1% lidocaine plus 40 mg TA
Number of subjects: 52

Group type: COMPARATOR
Intervention: Low-volume corticosteroid injections (LCI) - 4 mL total volume of 1% lidocaine plus 40 mg TA
Number of subjects: 52
Study: 26860772

Group type: EXPERIMENTAL
Intervention: Conventional ward-based program
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Technology-driven simulation-based strategy
Number of subjects: 24

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 24
Study: 24906419

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 397

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 397
Study: 22245891

Group type: EXPERIMENTAL
Intervention: Vandetanib 300mg/day
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Vandetanib 100mg/day
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Vandetanib (both doses)
Number of subjects: 67
Study: 20145196

Group type: EXPERIMENTAL
Intervention: Empowerment intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 19019210

Group type: EXPERIMENTAL
Intervention: 1.25 mg/day Tibolone
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: 2.5 mg/day Tibolone
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 15814585

Group type: EXPERIMENTAL
Intervention: Preventive health screening and health discussions
Number of subjects: 3464

Group type: COMPARATOR
Intervention: Control group (non-invited subjects)
Number of subjects: 3464
Study: 11918884

Group type: EXPERIMENTAL
Intervention: Total hepatic vascular exclusion (THVE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Selective hepatic vascular exclusion (SHVE)
Number of subjects: 0
Study: 10386418

Group type: EXPERIMENTAL
Intervention: Beating heart revascularization (off pump)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional revascularization with CPB at normothermia and cardioplegic arrest (on pump)
Number of subjects: 80
Study: 8880942

Group type: EXPERIMENTAL
Intervention: d-amphetamine (10 mg BID)
Number of subjects: 8

Group type: COMPARATOR
Intervention: placebo (0 mg BID)
Number of subjects: 8
Study: 1993229

Group type: EXPERIMENTAL
Intervention: Cultured allogenic epithelial grafts (CAGs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: OpSite (commercially available dressing)
Number of subjects: 0

Group type: COMPARATOR
Intervention: CAGs
Number of subjects: 0
Study: 6394505

Group type: EXPERIMENTAL
Intervention: Intravenous penicillin therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oral penicillin therapy
Number of subjects: 60
Study: 31479120

Group type: EXPERIMENTAL
Intervention: Intramyocardial injection of mesenchymal precursor cells
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 29106898

Group type: EXPERIMENTAL
Intervention: Focused Attention (FA) intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Open Monitoring (OM) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 26346687

Group type: EXPERIMENTAL
Intervention: Vitamin C 3%, Vitamin A 0.1%, Vitamin E 0.5%
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 26861164

Group type: EXPERIMENTAL
Intervention: Placebo administration after four prior administrations of apomorphine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Placebo administration after two, three, or four prior administrations of apomorphine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo administration for the first time
Number of subjects: 0
Study: 22872229

Group type: EXPERIMENTAL
Intervention: DMP (Therapie Aktiv)
Number of subjects: 801

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 801
Study: 20597828

Group type: EXPERIMENTAL
Intervention: Sensor-augmented insulin pump therapy (SAP group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard practice (Control group)
Number of subjects: 20
Study: 18367559

Group type: EXPERIMENTAL
Intervention: Autofluorescence imaging (AFI)
Number of subjects: 50

Group type: COMPARATOR
Intervention: White light endoscopy (WLE)
Number of subjects: 50
Study: 16266358

Group type: EXPERIMENTAL
Intervention: Topiramate (800 mg daily)
Number of subjects: 4
Study: 14562135

Group type: EXPERIMENTAL
Intervention: Acupuncture specific against erectile dysfunction (treatment group)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Acupuncture specific against headache (placebo group)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Simultaneous treatment with 50 mg sildenafil
Number of subjects: 22
Study: 10687576

Group type: EXPERIMENTAL
Intervention: Breast stimulation
Number of subjects: 79

Group type: COMPARATOR
Intervention: Oxytocin infusion
Number of subjects: 79
Study: 8739919

Group type: EXPERIMENTAL
Intervention: Captopril 50 mg twice daily
Number of subjects: 225

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 225
Study: 1747675

Group type: EXPERIMENTAL
Intervention: Four sessions of pelvic floor exercises and bladder retraining supervised by a non-specialist nurse who had taken a three week course on assessing and treating uncomplicated incontinence.
Number of subjects: 7300

Group type: COMPARATOR
Intervention: Control group (historical controls with no intervention for three months).
Number of subjects: 7300
Study: 6463176

Group type: EXPERIMENTAL
Intervention: Counting deviant stimuli
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reading a comic book
Number of subjects: 0
Study: 31170275

Group type: EXPERIMENTAL
Intervention: Mineralized cancellous bone allograft (MCBA)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Anorganic bovine bone mineral (ABBM)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Anorganic equine bone mineral (AEBM)
Number of subjects: 21
Study: 29108526

Group type: EXPERIMENTAL
Intervention: Sleep Treatment at Acute Crisis (STAC) plus Standard Care (SC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 40
Study: 27082758

Group type: EXPERIMENTAL
Intervention: Mouse
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Gesture-Controlled (Kinect)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Oral Instructions to Third Person
Number of subjects: 30
Study: 24126198

Group type: EXPERIMENTAL
Intervention: Adhesive patch method
Number of subjects: 100

Group type: COMPARATOR
Intervention: Circumferential belt method
Number of subjects: 100
Study: 22153770

Group type: EXPERIMENTAL
Intervention: FES‐CG (FES-assisted cycling)
Number of subjects: 20

Group type: COMPARATOR
Intervention: CG (cycling only)
Number of subjects: 20
Study: 18830646

Group type: EXPERIMENTAL
Intervention: Stereotactic fibrinolytic evacuation of intracerebral hemorrhage
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Urokinase and tissue plasminogen activator for lysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ongoing clinical trials evaluating the efficacy of stereotactic fibrinolysis
Number of subjects: 0
Study: 17604143

Group type: EXPERIMENTAL
Intervention: Curcuminoids at 2000 mg/day for 7 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 17233786

Group type: EXPERIMENTAL
Intervention: Testosterone gel
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 14984925

Group type: EXPERIMENTAL
Intervention: Physical exercise
Number of subjects: 0
Study: 11114313

Group type: EXPERIMENTAL
Intervention: Fludarabine (25 mg/m² IV daily for 5 days every 28 days)
Number of subjects: 509

Group type: COMPARATOR
Intervention: Chlorambucil (40 mg/m² orally every 28 days)
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Fludarabine (25 mg/m²)
Number of subjects: 509

Group type: COMPARATOR
Intervention: Chlorambucil (40 mg/m²)
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Fludarabine
Number of subjects: 509
Study: 9070491

Group type: EXPERIMENTAL
Intervention: Prophylactic radiotherapy
Number of subjects: 332

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 332
Study: 8369211

Group type: EXPERIMENTAL
Intervention: Nickel sulphate patch tests with a 10-step nickel sulphate dilution series (TRUE test)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo patches
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Nickel sulphate patch tests with high concentrations
Number of subjects: 72
Study: 3790957

Group type: EXPERIMENTAL
Intervention: 1 per cent topical povidone-iodine solution in addition to systemic antibiotics (gentamicin and metronidazole)
Number of subjects: 315

Group type: COMPARATOR
Intervention: Systemic antibiotics (gentamicin and metronidazole) without topical agent
Number of subjects: 315
Study: 30395965

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation
Number of subjects: 119

Group type: COMPARATOR
Intervention: Usual postoperative mobilization program
Number of subjects: 119
Study: 27681601

Group type: EXPERIMENTAL
Intervention: Pre-operative DVD and standard preparation
Number of subjects: 123

Group type: COMPARATOR
Intervention: Standard preparation
Number of subjects: 123
Study: 25546255

Group type: EXPERIMENTAL
Intervention: E-mail follow-up reminders
Number of subjects: 334

Group type: COMPARATOR
Intervention: Usual care discharge instructions
Number of subjects: 334
Study: 23990706

Group type: EXPERIMENTAL
Intervention: Etomidate emulsion group 1 (E1) - 10 μg · kg(‐1) · min(‐1) combined with remifentanil (0.1 μg · kg(‐1) · min(‐1))
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Etomidate emulsion group 2 (E2) - 15 μg · kg(‐1) · min(‐1) combined with remifentanil (0.2 μg · kg(‐1) · min(‐1))
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Etomidate emulsion group 3 (E3) - 20 μg · kg(‐1) · min(‐1) combined with remifentanil (0.2 μg · kg(‐1) · min(‐1))
Number of subjects: 110

Group type: COMPARATOR
Intervention: Propofol group (P group) - 610 mg · kg(‐1) · h(‐1)
Number of subjects: 110
Study: 20973889

Group type: EXPERIMENTAL
Intervention: PMMA implant
Number of subjects: 10

Group type: COMPARATOR
Intervention: Collagen implant
Number of subjects: 10
Study: 19248868

Group type: EXPERIMENTAL
Intervention: Psychoeducation-only (n=16)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Multifamily therapy plus psychoeducation (n=15)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Wait list (control; n=11)
Number of subjects: 42
Study: 16729277

Group type: EXPERIMENTAL
Intervention: 2 mg ibandronate every 2 months
Number of subjects: 1395

Group type: EXPERIMENTAL
Intervention: 3 mg ibandronate every 3 months
Number of subjects: 1395

Group type: COMPARATOR
Intervention: 2.5 mg oral ibandronate daily
Number of subjects: 1395

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 1395

Group type: EXPERIMENTAL
Intervention: All intravenous regimens
Number of subjects: 1395
Study: 15367193

Group type: EXPERIMENTAL
Intervention: Fluoride-containing mouthrinse
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo rinse
Number of subjects: 91
Study: 11343737

Group type: EXPERIMENTAL
Intervention: Quinapril 40 mg daily
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 9587008

Group type: EXPERIMENTAL
Intervention: Non-physician insertion of TCu380A IUD
Number of subjects: 367

Group type: COMPARATOR
Intervention: Physician insertion of TCu380A IUD
Number of subjects: 367
Study: 7988783

Group type: EXPERIMENTAL
Intervention: HLA class II alleles, haplotypes and genotypes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DR4 associated DRB1 and DQB1 alleles
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DPB1*0202
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extended haplotypes for DR2, DR11, and DR13
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DQA1/DQB1 genotypes (4SS heterodimers)
Number of subjects: 0
Study: 2656929

Group type: EXPERIMENTAL
Intervention: Intravenous ciprofloxacin therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: i.v. ceftazidime
Number of subjects: 0
Study: 31874318

Group type: EXPERIMENTAL
Intervention: Seating chart intervention
Number of subjects: 1573

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 1573
Study: 31668688

Group type: EXPERIMENTAL
Intervention: Treadmill exercise (6 months)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Whole-body stretching (6 months)
Number of subjects: 25
Study: 28541864

Group type: EXPERIMENTAL
Intervention: Primary closure
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Delayed primary closure
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Vacuum‐assisted closure
Number of subjects: 81
Study: 25923485

Group type: EXPERIMENTAL
Intervention: Bilberry extract (BE) 480 mg/day
Number of subjects: 281

Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 281
Study: 23592479

Group type: EXPERIMENTAL
Intervention: Ghrelin administration (300 min, supraphysiological dose)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ghrelin administration
Number of subjects: 10
Study: 21762197

Group type: EXPERIMENTAL
Intervention: MTZ+AMX (500 mg t.i.d.) for 14 days
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: MTZ (400 mg t.i.d.) for 14 days
Number of subjects: 51

Group type: COMPARATOR
Intervention: SRP only
Number of subjects: 51
Study: 19806062

Group type: EXPERIMENTAL
Intervention: Visual acuity better than 0.2 LogMAR
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visual acuity between -0.2 and 0.6 LogMAR
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visual acuity of 0.0 LogMAR or better
Number of subjects: 0

Group type: COMPARATOR
Intervention: Visual acuity equal to or worse than 0.7 LogMAR
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visual acuity between 0.3 and 0.4 LogMAR
Number of subjects: 0
Study: 17079372

Group type: EXPERIMENTAL
Intervention: Birmingham hip resurfacing
Number of subjects: 10

Group type: COMPARATOR
Intervention: Nonresurfaced hips
Number of subjects: 10
Study: 15043491

Group type: EXPERIMENTAL
Intervention: Cognitive Decline evaluated through the Blessed Scale
Number of subjects: 100
Study: 11251657

Group type: EXPERIMENTAL
Intervention: Stringent aspiration protocol (group S)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Non-stringent aspiration protocol (group NS)
Number of subjects: 24
Study: 9249100

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TA) 2 mg x kg(‐1) x h(‐1)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 32
Study: 7686100

Group type: EXPERIMENTAL
Intervention: Plastic stents (14 French)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Metal stents (24 French)
Number of subjects: 20
Study: 10285531

Group type: EXPERIMENTAL
Intervention: Mailed booklet preoperative instruction
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Teaching performed by nurses after hospital admission
Number of subjects: 66

Group type: COMPARATOR
Intervention: No instruction (control group)
Number of subjects: 66

Group type: COMPARATOR
Intervention: All groups (including control)
Number of subjects: 66
Study: 30366067

Group type: EXPERIMENTAL
Intervention: Insulin glargine 300 U/mL (Gla-300)
Number of subjects: 2496

Group type: COMPARATOR
Intervention: Insulin glargine 100 U/mL (Gla-100)
Number of subjects: 2496
Study: 29609630

Group type: EXPERIMENTAL
Intervention: Group cognitive behavioral therapy (CBT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Wait-list control (WL)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Group CBT
Number of subjects: 50
Study: 28807031

Group type: EXPERIMENTAL
Intervention: Interleukin-6 measured in plasma
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Cortisol measured in plasma
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Lipoxin A4 measured in plasma
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Resolvin D measured in plasma
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Postoperative complications
Number of subjects: 41
Study: 26331623

Group type: EXPERIMENTAL
Intervention: Small-Sided Games (SSG)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Interval Training (IT)
Number of subjects: 17
Study: 23414701

Group type: EXPERIMENTAL
Intervention: Subsyndromal depression without comorbid anxiety disorders
Number of subjects: 247

Group type: COMPARATOR
Intervention: Subsyndromal depression with comorbid anxiety disorders
Number of subjects: 247
Study: 21514794

Group type: EXPERIMENTAL
Intervention: Long-acting injectable risperidone
Number of subjects: 10010
Study: 17947500

Group type: EXPERIMENTAL
Intervention: Saturated fatty acids (SFA)
Number of subjects: 7

Group type: COMPARATOR
Intervention: n-6 polyunsaturated fatty acids (PUFA)
Number of subjects: 7
Study: 16476915

Group type: EXPERIMENTAL
Intervention: Balance training program
Number of subjects: 765

Group type: COMPARATOR
Intervention: Standard conditioning exercises (Control)
Number of subjects: 765
Study: 12831948

Group type: EXPERIMENTAL
Intervention: Diet containing 1.0 mg of Cu/2000 kcal and 99 mg of Mg/2000 kcal for 81 days
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Diet containing 1.0 mg of Cu/2000 kcal and 399 mg of Mg/2000 kcal for 81 days
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Diet containing 3.0 mg of Cu/2000 kcal and 99 mg of Mg/2000 kcal for 81 days
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Diet containing 3.0 mg of Cu/2000 kcal and 399 mg of Mg/2000 kcal for 81 days
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Low dietary copper
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Magnesium deprivation
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Low dietary magnesium and low dietary copper
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Magnesium deprivation with luxuriant copper
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Magnesium deprivation with low dietary copper
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: High dietary magnesium before depletion
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 100 mg of Mg/d
Number of subjects: 19
Study: 11111106

Group type: EXPERIMENTAL
Intervention: Acid perfusion
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline perfusion
Number of subjects: 12
Study: 9155573

Group type: EXPERIMENTAL
Intervention: Omeprazole (8 mg/hour after a bolus of 80 mg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ranitidine (0.25 mg/kg/hour after a bolus of 50 mg)
Number of subjects: 40
Study: 7970431

Group type: EXPERIMENTAL
Intervention: Two-phase (flow and static) scrotal scintigraphy
Number of subjects: 43
Study: 3297481

Group type: EXPERIMENTAL
Intervention: Kathon CG 15 ppm active ingredient in a leave-on body lotion
Number of subjects: 209

Group type: COMPARATOR
Intervention: Control lotion without Kathon CG
Number of subjects: 209
Study: 31263013

Group type: EXPERIMENTAL
Intervention: Liquid artificial tears (Lacribell; Latinofarma)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Artificial tears gel (Vidisic Gel; Bausch and Lomb)
Number of subjects: 140
Study: 27740878

Group type: EXPERIMENTAL
Intervention: AZD5423 (selective glucocorticoid receptor modulator)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulated airway tissue exposure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Variations in systemic exposure (plasma concentration profile, AUC, Cmax)
Number of subjects: 0
Study: 24877682

Group type: EXPERIMENTAL
Intervention: Carpal tunnel syndrome (CTS)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Visual feedback provided for the first 30 seconds
Number of subjects: 22
Study: 23964934

Group type: EXPERIMENTAL
Intervention: Pazopanib (800 mg once daily)
Number of subjects: 1110

Group type: COMPARATOR
Intervention: Sunitinib (50 mg once daily for 4 weeks, followed by 2 weeks without treatment)
Number of subjects: 1110

Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 1110

Group type: EXPERIMENTAL
Intervention: Pazopanib
Number of subjects: 1110
Study: 22024490

Group type: EXPERIMENTAL
Intervention: NUTRIOSE 8 g/d
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: NUTRIOSE 14 g/d
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: NUTRIOSE 18 g/d
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: NUTRIOSE 24 g/d
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 18804132

Group type: EXPERIMENTAL
Intervention: IC51 vaccine in TBE ELISA-positive subjects
Number of subjects: 420

Group type: COMPARATOR
Intervention: IC51 vaccine in TBE ELISA-negative subjects
Number of subjects: 420
Study: 17227526

Group type: EXPERIMENTAL
Intervention: Optical coherence tomography (OCT) imaging
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: OCT imaging in active UC segments
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: OCT imaging in normal sites above affected segments
Number of subjects: 27
Study: 15040548

Group type: EXPERIMENTAL
Intervention: Individuals with Parkinson's disease
Number of subjects: 42

Group type: COMPARATOR
Intervention: Nondemented individuals without Parkinson's disease
Number of subjects: 42
Study: 14509504

Group type: EXPERIMENTAL
Intervention: Fibrin glue (3 ml applied to the dissected mediastinum)
Number of subjects: 43

Group type: COMPARATOR
Intervention: No fibrin glue applied
Number of subjects: 43
Study: 10232311

Group type: EXPERIMENTAL
Intervention: Co-trimoxazole (trimethoprim 160 mg, sulphamethoxazole 800 mg) daily
Number of subjects: 545

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 545

Group type: EXPERIMENTAL
Intervention: Co-trimoxazole
Number of subjects: 545